42 computer-programmer Fellowship positions at University of Birmingham in United Kingdom
Sort by
Refine Your Search
-
initiative improving outcomes in diabetes emergencies PCOS SEVa – a national programme addressing variation in the quality of care for polycystic ovary syndrome (PCOS) Role Summary Work within specified
-
will lead a project funded by the Grace Kelly Cancer Childhood Trust to test the performance of this tool, further develop and improve the tool, increase the number and range of tumours the programme
-
Birmingham Professional programme which provides all professional services staff with development opportunities and the encouragement to reach their full potential. With almost 5,000 professional services jobs
-
at the University of Birmingham is pleased to offer a Part-Time Research Fellow post funded through the NIHR DEMCOMM Fellowship Programme. This post supports a motivated qualitative researcher to contribute
-
July 2025 Background To create and contribute to the creation of knowledge by undertaking a specified range of activities within an established research programme and/or specific research project. Role
-
contribute to the creation of knowledge by undertaking a specified range of activities within an established research programme and/or specific research project. Our international group of highly motivated and
-
to broader management/administration processes Contribute to the planning and organising of the research programme and/or specific research project Co-ordinate own work with others to avoid conflict
-
to broader management/administration processes Contribute to the planning and organising of the research programme and/or specific research project Co-ordinate own work with others to avoid conflict
-
dedicated to open, inclusive and inspiring research spaces for academics and their collaborators. In addition, the University of Birmingham offers exceptional High Performance Computing facilities, including
-
(HPB). The medical oncology grouping sees close to 550 new cases of these cancers a year. There is a large active clinical trials programme that spans phase 1 to phase 3. These patients have a poor